Daily Morning Note – 25 Febraury 2021


The Dow finished at a fresh record on Wednesday, shaking off early weakness following dovish comments from the Federal Reserve chief and progress on another coronavirus vaccine.

The Dow Jones Industrial Average jumped 1.4 per cent to close at 31,961.86, a new all-time high.

The broad-based S&P 500 gained 1.1 per cent to end at 3,925.43, while the tech-rich Nasdaq Composite Index advanced 1.0 per cent to 13,597.97 after two days of declines.

Appearing for a second day of congressional testimony, Fed Chair Jerome Powell reiterated his expectations that inflation will remain mild and that interest rates will stay low for a while longer.



United Overseas Bank Ltd reported a 32 per cent fall in quarterly profit as Singapore’s smallest listed bank said its net interest income declined and credit losses swelled. UOB said on Thursday that October-December net profit slumped to S$688 million from a year earlier, in line with an average estimate of S$696.3 million of four analysts, according to data from Refinitiv

Netlink NBN Trust’s net profit was S$69.5 million for the nine months ended Dec 31, 2020, up 5.9 per cent from S$65.6 million in the corresponding period of the previous year. NetLink NBN Management reported on Wednesday night that earnings before interest, taxes, depreciation and amortisation (Ebitda) improved 3.6 per cent to S$209.9 million from S$202.6 million a year ago. This included government relief grants and lower operation and maintenance costs. Revenue edged down to S$276.3 million from S$277.8 million. Installation revenue fell by S$5 million, but was offset by higher residential, non-building address point (NBAP) and segment connections revenue.

Supermarket operator Sheng Siong on Wednesday posted a net profit of S$32.1 million for the fourth quarter ended Dec 31, up 84.9 per cent from S$17.4 million a year ago. Riding on elevated demand driven by the pandemic, revenue rose 28.8 per cent to S$319.3 million from S$247.9 million in Q4 2019. The increase was attributed to better performance at existing stores (18.2 percentage points) and new stores opened in 2020 (10.6 percentage points). Earnings per share stood at 2.13 Singapore cents, up from 1.16 cents previously. For the full year, Sheng Siong’s net profit was S$139.1 million, or 83.7 per cent higher than the S$75.8 million reported for FY2019.

OUE Lippo Healthcare (OUELH) has been allotted about 163.3 million units of the rights issue of First Real Estate Investment Trust (First Reit), OUELH said in a bourse filing on Wednesday evening. Following the completion of the rights issue, OUELH indirectly owns approximately 15.4 per cent of the total number of First Reit units in issue, or about 246.9 million units.


India’s largest renewable energy firm ReNew Power said on Wednesday it would go public through a US$8 billion merger with a blank-cheque firm in the biggest deal in the fast-growing clean energy sector in the country. The deal will be financed with cash proceeds of US$1.2 billion, including US$855 million in investments from serial blank-cheque dealmaker Chamath Palihapitiya, funds managed by BlackRock and Sylebra Capital. It is among a wave of clean-energy firms poised to benefit from the country’s push into renewable energy.

Lowe’s said fourth-quarter same-store sales climbed 28.1%, as consumers spent more on home projects during the pandemic. Same-store sales climbed 28.1%, outpacing estimates that called for a 22% gain. Lowe’s reiterated its prior forecast, which says spending on DIY projects and home improvement could ease as consumers resume normal activities post-pandemic.

Bitcoin climbed, aided by supportive comments from Ark Investment Management’s Cathie Wood and news that Square boosted its stake in the cryptocurrency. Overall investor sentiment has also been boosted by comments Tuesday from Federal Reserve chair Jerome Powell, who signalled the central bank is nowhere close to unwinding its easy policy. Cryptocurrencies have been buoyed by a tide of monetary and fiscal stimulus to fight the impact of the pandemic.

Johnson & Johnson’s, one-shot COVID-19 vaccine appeared safe and effective in trials, US Food and Drug Administration (FDA) staff said, paving the way for its approval for emergency use. The FDA’s panel of independent experts meets on Friday to decide whether to approve the shot. While it is not bound to follow the advice of its experts, the FDA usually does and has authorised vaccines from Pfizer and Moderna.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR


Sembcorp Industries – Energy demand improving

Recommendation: Accumulate (Downgrade), Last Done: S$1.66

Target price: S$1.77, Analyst: Terence Chua

– Net profit before exceptional items of S$301mn came ahead of our loss estimates of S$147mn. The variance came from better-than-expected energy revenue.

– Energy demand and prices improved sequentially in 4Q20 vs. 3Q20 in their key markets.

– We raise our target price to S$1.77 from S$1.75 as we peg SCI to 0.85x FY21 P/B, closer to their 10-year historical average P/B up from 0.7x previously as we see the outlook improving and expect the Group to report stronger operating metrics from FY21e. As most of the positives have already been priced in, we downgrade from BUY to ACCUMULATE

>> Read more research reports

HK Reports – Read up on our Hong Kong reports here

Webinar Of The Week

Market Outlook: Q&M (Initiation), ART, AREIT, YOMA, MMH, UGHC, Banking Monthly & SG Weekly

Date: 08 February 2021

For more on Market Outlook

Updates summarised in 3 minutes

Phillip Research in 3 minutes: #29 – Keppel Corporation; Initiation

For more videos on Phillip in 3 Mins

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com